Knockdown of CARMA1 in human T-ALL cell lines conferred a survival advantage to mouse hosts, and T-ALL patients with CNS involvement had elevated CARMA1 levels in the BM, supporting a role for CARMA1 in promoting CNS disease in T-ALL patients134. Here, CARD11 is linked to acute lymphoblastic leukemia.